VPIM
CGTX icon

Vanguard Personalized Indexing Management’s Cognition Therapeutics CGTX Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio CGTX Stock Details CGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.38K Buy
+11,034
New +$12.8K ﹤0.01% 2158
2025
Q2 		– Sell
-56,002
Closed -$23.6K – 1961
2025
Q1 		$23.6K Buy
+56,002
New +$32.9K ﹤0.01% 1755

Other funds holding CGTX

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HCM
Hilton Capital Management Garden City, New York $1.32B AUM 15.59% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

Vanguard Personalized Indexing Management's CGTX Position: Q1 2026 in Review

Vanguard Personalized Indexing Management opened a new position in Cognition Therapeutics (CGTX) in Q1 2026: 11,034 shares worth $8.38K. The stake represents ﹤0.01% of the portfolio and ranks #2158 among its holdings. This is a return to the name: Vanguard Personalized Indexing Management previously reported a position in CGTX as recently as Q1 2025.

Vanguard Personalized Indexing Management first reported a position in CGTX in Q1 2025 and has held it in 2 quarters since. The position peaked at $23.6K in Q1 2025. 75 funds tracked by Wall St. Rank hold CGTX as of Q1 2026.

  • Vanguard Personalized Indexing Management held 11,034 shares of Cognition Therapeutics worth $8.38K as of Q1 2026.
  • Cognition Therapeutics was a new Vanguard Personalized Indexing Management position in Q1 2026.
  • Cognition Therapeutics made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q1 2026, its #2158 holding.
  • Vanguard Personalized Indexing Management first reported a position in Cognition Therapeutics in Q1 2025 and has held it in 2 quarters since.
  • Vanguard Personalized Indexing Management's Cognition Therapeutics position peaked at $23.6K in Q1 2025.
  • 75 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q1 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q1 2026, filed 14 May 2026.